Kasvu Therapeutics
Kasvu Therapeutics develops small-molecule treatments intended to stimulate neuroplasticity without the hallucinogenic effects associated with psychedelic drugs.
€30MSeries A
ParticipantSI
Stephen Industries
Activity from announced rounds
Activity in this selectionOct 11, 2026 · Europe · Jan 1, 2026
Stephen Industries is the corporate investor named by AlixLabs and in Kasvu financing coverage.
Recorded funding activity
AlixLabs develops semiconductor etching processes. Kasvu develops non-hallucinogenic neuroplasticity treatments, while Anferra recycles steel waste. The records retain distinct technologies and keep unpublished participation in draft.
- Rounds participated in
- 3
- Confirmed lead rounds
- 0 1 roles undisclosed
- New companies
- 3 First participation on record · 0 follow-on
- Funding in participating rounds
- $51.8M 2 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
3 in this selectionAnferra AB
Anferra develops a recycling process that turns steel grinding waste into iron chloride for water treatment, hydrogen and recoverable alloy materials.
UndisclosedStrategic
Role not disclosedAlixLabs
AlixLabs develops atomic-layer etching processes and equipment for semiconductor manufacturers making smaller, more densely packed chip features.
€15MSeries A
Participant